Global Use of Bovine Heparin: Challenges and Opportunities.
- Published in:
- Proteoglycan Research, 2025, v. 3, n. 2, p. 1, doi. 10.1002/pgr2.70025
- By:
- Publication type:
- Article
Works matching AU Tovar, Ana M. F.
Results: 6
1
2
A unique fucosylated chondroitin sulfate type II with strikingly homogeneous and neatly distributed α-fucose branches.
- Published in:
- Glycobiology, 2018, v. 28, n. 8, p. 565, doi. 10.1093/glycob/cwy048
- By:
- Publication type:
- Article
3
Systematic Analysis of Pharmaceutical Preparations of Chondroitin Sulfate Combined with Glucosamine.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 2, p. 38, doi. 10.3390/ph10020038
- By:
- Publication type:
- Article
4
Bovine and porcine heparins: different drugs with similar effects on human haemodialysis.
- Published in:
- BMC Research Notes, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-0500-6-230
- By:
- Publication type:
- Article
5
Update on Brazilian biosimilar enoxaparins.
- Published in:
- Expert Review of Hematology, 2016, v. 9, n. 11, p. 1015, doi. 10.1080/17474086.2016.1243052
- By:
- Publication type:
- Article
6
Structural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugs.
- Published in:
- Scientific Reports, 2016, p. 35619, doi. 10.1038/srep35619
- By:
- Publication type:
- Article